1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for RZLT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2013. Start Trial.
Date Value
September 11, 2026 -47.05%
September 10, 2026 -48.52%
September 09, 2026 -49.75%
September 08, 2026 -44.65%
September 04, 2026 -37.94%
September 03, 2026 -37.29%
September 02, 2026 -36.40%
September 01, 2026 -36.80%
August 31, 2026 -34.13%
August 28, 2026 -36.01%
August 27, 2026 -30.83%
August 26, 2026 -30.00%
August 25, 2026 -28.43%
August 24, 2026 -28.43%
August 21, 2026 -26.87%
August 20, 2026 -30.03%
August 19, 2026 -27.05%
August 18, 2026 -28.86%
August 17, 2026 -28.00%
August 14, 2026 -28.79%
August 13, 2026 -28.90%
August 12, 2026 -24.19%
August 11, 2026 -22.22%
August 10, 2026 -19.45%
August 07, 2026 -15.80%
Date Value
August 06, 2026 -17.40%
August 05, 2026 -20.14%
August 04, 2026 -15.76%
August 03, 2026 -16.35%
July 31, 2026 -20.67%
July 30, 2026 -18.80%
July 29, 2026 -23.70%
July 28, 2026 -22.88%
July 27, 2026 -21.59%
July 24, 2026 -14.99%
July 23, 2026 -9.69%
July 22, 2026 -6.89%
July 21, 2026 -5.39%
July 20, 2026 -17.44%
July 17, 2026 -16.79%
July 16, 2026 -18.32%
July 15, 2026 -7.24%
July 14, 2026 -9.21%
July 13, 2026 -9.89%
July 10, 2026 -9.52%
July 09, 2026 -2.84%
July 08, 2026 -0.20%
July 07, 2026 -0.20%
July 06, 2026 2.28%
July 02, 2026 1.03%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. 510.8%
AbbVie, Inc. 20.38%
Marker Therapeutics, Inc. 18.54%
Avalo Therapeutics, Inc. 48.16%
Krystal Biotech, Inc. 140.4%